Upgrade to SI Premium - Free Trial

Nektar Therapeutics (NKTR) PT Raised to $20 at Oppenheimer

November 7, 2019 10:24 AM
Oppenheimer analyst Jay Olson raised the price target on Nektar Therapeutics (NASDAQ: NKTR) to $20.00 (from $18.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles